---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-26-012132"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2026-09-29T10:30:19+00:00"
generated_at: "2026-10-12T13:41:02.036211+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro presents Phase 1/2A AL001 lithium brain-imaging data at ISMRT on Sept. 29, 2026

## Summary
- Dr. Ovidiu C. Andronesi presented Phase 1/2A results at the ISMRT Workshop on Sept. 29, 2026, covering 30 participants: 6 each healthy, bipolar, major depression, Alzheimer's, and PTSD.
- AL001 is a lithium salicylate/L-proline co-crystal; trial NCT06921590 used 7T Terra.X MRI and compared AL001 with Li2CO3 in a randomized crossover.
- Brain Li concentration trended higher after AL001 (geometric mean 4020.64 ng/g, 64% CV) vs Li2CO3 (3476.94 ng/g, 57% CV), but differences were not statistically significant.
- Non-compartmental PK AUC trended higher for AL001 (geometric mean 62230 h*ng/g, 26% CV) vs Li2CO3 (59715 h*ng/g, 25% CV); two-compartment modeling showed higher white-matter K1.
- 92% of lithium images were scored excellent to adequate, with Gwet's agreement coefficient 0.73 (95% CI 0.66-0.80).

## SEC filing metadata
- accession: 0001214659-26-012132
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2026-09-29T10:30:19+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465926012132/0001214659-26-012132-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465926012132/x9282618k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-26-012132
- JSON: https://secwatch.observer/filing/0001214659-26-012132.json
- Plain text: https://secwatch.observer/filing/0001214659-26-012132.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.